CANCER GENETICS, INC (CGIX) has 47 open-market insider trades by 13 insiders since 2013. The most active filer is John Pappajohn, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| John Pappajohn | Dir | — | 22 | $4.4M | 2019-01-31 |
| John Pappajohn | Dir | — | 12 | $2.4M | 2019-01-31 |
| Raju S.k. Chaganti | Dir | — | 2 | $855K | 2017-09-28 |
| Andrew L. Pecora | Dir | — | 1 | $713K | 2013-11-18 |
| Geoffrey E. Harris | Dir | — | 5 | $98K | 2019-01-14 |
| John A. Roberts | CEO | — | 3 | $90K | 2019-01-31 |
| Michael Glenn Miles | CFO | — | 1 | $35K | 2019-01-31 |
| Edward J. Sitar | CFO | — | 4 | $26K | 2016-11-16 |
| Edmund Cannon | Dir | — | 1 | $10K | 2019-01-31 |
| Igor Gitelman | Chief Accounting Officer | — | 1 | $7K | 2017-05-25 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Edmund Cannon | Director | Buy | $10K | 2019-01-31 |
| John Pappajohn | Director | Buy | $230K | 2019-01-31 |
| Michael Glenn Miles | CFO | Buy | $35K | 2019-01-31 |
| John A. Roberts | CEO | Buy | $43K | 2019-01-31 |
| John Pappajohn | Director | Buy | $230K | 2019-01-14 |
| John A. Roberts | CEO | Buy | $23K | 2019-01-14 |
Companies that share insiders with CGIX, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| John A. Roberts | COO | Buy | $24K | 2017-12-15 |
| John Pappajohn | Director & 10% | Buy | $279K | 2017-12-08 |
| John Pappajohn | Director & 10% | Buy | $66K | 2017-08-17 |
| John Pappajohn | Director & 10% Owner | Buy | $280K | 2017-08-17 |
| John Pappajohn | Director & 10% | Buy | $375K | 2017-06-12 |
| Igor Gitelman | Chief Accounting Officer | Buy | $4K | 2017-05-25 |
| Igor Gitelman | Chief Accounting Officer | Sell | $4K | 2017-05-23 |
| John Pappajohn | Director & 10% | Buy | $73K | 2017-05-16 |
| Geoffrey E. Harris | Director | Buy | $9K | 2017-05-16 |